Antimicrobial Discovery Solutions

Antimicrobial Discovery Solutions (ADS) is a UK-based biotechnology company and University of Warwick spin-out specializing in the discovery and development of new antibiotics to combat antimicrobial resistance (AMR). The company provides a range of specialized services, including biochemical assays, structural biology, and microbiology, alongside the supply of high-quality peptidoglycan reagents. ADS leverages its proprietary assay platforms to identify novel inhibitors of essential bacterial targets such as Mur ligases and tRNA synthetases. Through strategic partnerships with academic and industrial organizations, the company facilitates the progression of early-stage antimicrobial candidates toward clinical development. Its expertise in cell wall biosynthesis and protein synthesis targets positions it as a key player in the early-stage antibacterial R&D ecosystem.